Sumpatan, Noralyn T.

HRN: 23-18-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/21/2023
IV
1.5gms
Q8hrs
Meconium Stained Amniotic Fluid; Leucocytosis
Waiting Final Action 
06/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/19/2023
06/21/2023
IV
500mg
Q8hrs
Meconium Stained Amniotic Fluid; Leukocytosis
Waiting Final Action 
07/14/2024
CEFUROXIME 500MG (TAB)
07/14/2024
07/20/2024
PO
500mg
BID
S/P RMLE & Repair
Waiting Final Action 
07/14/2024
MEBENDAZOLE 500MG (TAB)
07/14/2024
07/20/2024
PO
500mg
TID
Meconium Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: